Divergent metabolism between Trypanosoma congolense and Trypanosoma brucei results in differential sensitivity to metabolic inhibition. (2021)
Attributed to:
A new drug discovery pipeline for animal African trypanosomiasis
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.ppat.1009734
PubMed Identifier: 34310651
Publication URI: http://europepmc.org/abstract/MED/34310651
Type: Journal Article/Review
Volume: 17
Parent Publication: PLoS pathogens
Issue: 7
ISSN: 1553-7366